56
Views
2
CrossRef citations to date
0
Altmetric
Case Report

A case of probable oxybutynin-induced increase in liver enzymes

, , , &
Pages 1657-1660 | Published online: 10 Sep 2018

Figures & data

Figure 1 Liver enzymes levels during hospital stay.

Notes: On 7/4/2017, atorvastatin was suspended and mild decrease noted. When liver enzymes started to increase again, on 26/4/2017, escitalopram was suspended and they started to lower after few days. Oxybutynin was started on 6/5/2017, and the enzymes elevated again within a week. On 15/5/2017, oxybutynin was suspended and, in few days, a decrease in liver enzymes was noted.
Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase.
Figure 1 Liver enzymes levels during hospital stay.

Figure 2 ALT and AST levels during hospital stay.

Notes: After suspending atorvastatin, on 20/4/2017, a clear drop is noted. After suspending escitalopram due to repeated elevation, on 6/5/2017, the enzymes fell again, and oxybutynin was started on the same day. Within a week, elevation of liver enzymes occurred again, so oxybutynin was suspended on 15/5/2017 and the enzymes started to fall reaching baseline values in the following few days.
Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase.
Figure 2 ALT and AST levels during hospital stay.

Table 1 Naranjo adverse drug reaction scale